Retatrutide 10 MG

### High-Purity Triple-Incretin Agonist Formulation

Retatrutide (10 MG) is a next-generation multi-agonist synthetic peptide engineered to selectively target glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCGR) receptor pathways.

Provided in an optimal 10 MG mass for dose-response titration, acute receptor kinetics, and comparative cellular signaling workflows. Produced via automated Solid-Phase Peptide Synthesis (SPPS) and vacuum-lyophilized for maximum shelf stability.

### Investigational Domains

• **Receptor Sensitivity**: Tri-agonist receptor binding affinity in engineered cellular lines.

• **Signaling Transduction**: Intracellular cAMP generation and downstream enzymatic activity.

• **Metabolic Modulation**: Assessed in adipocyte lipid turnover and hepatic cell respiration assays.

### Chemical Specifications

• **Molecular Formula**: C221H342N56O67S2

• **Molecular Weight**: ~4845.5 g/mol

• **Purity**: ?99.0% (RP-HPLC confirmed)

• **Physical Form**: White Lyophilized Cake

• **Sterility**: Membrane filtered at 0.22 ??m

### Storage & Reconstitution

• Store unopened lyophilized vial at -20??C in the dark.

• Reconstitute with 1-2 mL sterile Bacteriostatic Water. Store reconstituted solution at 2??C to 8??C for up to 28 days.